Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine With or Without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02627443
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:56.917712+00:00
Published At
2026-04-02T00:00:00+00:00
Record Updated At
2026-04-13
Results Posted At
2026-04-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Fallopian Tube Carcinoma", "Metastatic Ovarian Carcinoma", "Metastatic Primary Peritoneal Carcinoma", "Ovarian Endometrioid Tumor", "Ovarian High Grade Serous Adenocarcinoma", "Platinum-Sensitive Ovarian Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma", "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Primary Peritoneal Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-13"
protocolSection.identificationModule.nctId
"NCT02627443"
protocolSection.identificationModule.officialTitle
"Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine With or Without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-04-02"

Study condition terms

  • Metastatic Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Endometrioid Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Sensitive Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.